Category

Clinical Trials

FDA approved

Follicum’s Phase II study approved by the German Medicines Agency

January 30, 2020

Follicum has received approval from …

Magnus Jäderberg

Encouraging data from Targovax

January 28, 2020

Targovax has announced the first …

Jose Baselga

AstraZeneca’s Phase II DESTINY-Gastric01 trial met primary endpoint

January 27, 2020

The AstraZeneca trial met primary …

AstraZeneca Research and Development

AstraZeneca’s Brilinta met primary endpoint

January 27, 2020

Brilinta reduced the risk of …

Washington

A Nordic precision medicine goldmine

Chris Tachibana

January 25, 2020

The combined Nordic population is …

Uli Hacksell

Medivir phase II study published in Annals of Internal Medicine

January 22, 2020

Medivir has announced that the …

Anna Ljung

Update on Moberg Pharma Trial

January 22, 2020

Moberg Pharma has completed the …

Mene Pangalos

AstraZeneca closes its Phase III STRENGTH trial for Epanova

January 14, 2020

Following the recommendation from an …

erik-kinneman

Neurovive completes recruitment in Phase 1a/b study

January 13, 2020

NeuroVive Pharmaceutical has announced the …

Immunovia achieves major milestone

January 8, 2020

Immunovia has announced that the …

Richard Godfrey

BerGenBio presents preliminary clinical data

January 7, 2020

BerGenBio has provided an update …

First patient dosed with Alligator’s ATOR-1017 developed for metastasized cancer

December 19, 2019

The first patient has been …

Annette Säfholm

Gedea Biotech reports last patient visit in vulvovaginal candidiasis clinical study

December 19, 2019

Gedea Biotech has announced that …

Positive human ex vivo data from Follicum

December 17, 2019

Follicum has announced that data …

cantargia

Cantargia selects CAN10 as development project in systemic sclerosis and myocarditis

December 12, 2019

Cantargia has announced that its …

BioArctic’s partner Eisai presents new trial data

December 12, 2019

BioArctic has announced that data …

1
2
3
4
···
28